As a part of SABZ Biomedicals’ Portfolio, we provide consulting services for medical institutions, biomedical companies, and academic organizations that want to implement or initiate CAR T cell therapy, from concept to practice. Our advisory board consists of biotechnology academic and industry leaders with particular expertise in genetic-engineering, cell & gene therapy bioprocessing and GLP/GMP experience. As a Contract Service, we provide strategic guidance to design CAR T cell-based research and progress it into the translational development and manufacturing stage. Advisory board provides Consulting Services in the following areas: